Device Trial Radar · NCT02379923
The Asahi Intecc PTCA Chronic Total Occlusion Study
Last checked: Nov 20, 2026Latest source record: Jul 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
163
Actual
Start
Jun 2015
Primary completion
Jan 2016
Study completion Jan 2016
Sponsor
- Lead sponsor
- Asahi Intecc USA IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medpace, Inc.
- First posted
- Mar 5, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to evaluate confirmation of placement of any guidewire beyond the chronic total occlusion (CTO) in the true vessel lumen in patients in which at least one Asahi series of guidewires and/or Corsair microcatheter were used. Procedure success will be defined as angiographic visualization of any guidewire in a position either distal or proximal to the occlusion depending on the route of access and the absence of in-hospital major adverse cardiac events (MACE).
Conditions
- Coronary Artery Disease
- Coronary Artery Chronic Total Occlusion
Interventions
Crossing of Coronary Artery CTODevice
Standard angiographic procedures will be followed for this study. The primary objective of this trial is to evaluate confirmation of placement of any guidewire beyond the chronic total occlusion (CTO) in the true vessel lumen in patients in which at least one Asahi series of guidewires and/or Corsair microcatheter were used. Procedure success will be defined as angiographic visualization of any guidewire in a position either distal or proximal to the occlusion depending on the route of access and the absence of in-hospital MACE. Other Name: ASAHI Corsair Microcatheter, ASAHI PTCA Guide Wires
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedure SuccessTime frame: Through hospital discharge, typically 24 hours post procedure
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Banner - University Medical Center Phoenix
Phoenix, Arizona
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.